Hematotropic

Substitutes for plasma and other blood components are designed to replenish the BCC, maintain its aggregate state, replace certain blood functions (leukocyte mass, plasma preparations, platelet concentrate), maintain water and electrolyte balance, oncotic blood pressure, and correct acid base balance. Drugs of this group are also used as detoxifying agents that have the ability to…

Read More Substitutes for plasma and other blood components

Fibrinolytics, or fibrinolytic agents, cause the destruction of the formed fibrin filaments; they contribute mainly to the resorption of fresh (not yet organized) blood clots. Fibrinolytic agents are divided into groups of direct and indirect action. The first group includes substances that directly affect blood plasma, a clot of fibrin filaments, effective in vitro and…

Read More Fibrinolytics

Drugs in this group stimulate erythro- and leukopoiesis. As such drugs, substances of various groups are used: synthetic derivatives of pyrimidine (methyluracil, pentoxil); colony-stimulating factors (filgrastim, molgramostim), vitamins – cyanocobalamin and folic acid, various iron-containing agents and other drugs (Ceruloplasmin, etc.). Below is a list of hematopoietic stimulants: Folic acid Iron chloride (Ferri chloridum) Darbepoetin…

Read More Hematopoietic stimulants

This pharmacological group includes such hematotropic agents as coagulants (including blood coagulation factors), hemostatics in combinations. Below is a list of coagulants (including blood coagulation factors), hemostatics in combinations: Clotting factor VIII + von Willebrand factor Boric acid + Nitrofural + [Collagen]

Read More Coagulants, including blood clotting factors, hemostatics in combinations

To prevent and stop bleeding, drugs that increase blood clotting (hemostatics) are used. Hemostatic agents are represented by drugs of different groups and differ in their mechanism of action. Locally, to stop capillary and parenchymal bleeding, Thrombin (a preparation of natural thrombin) and other local hemostatics (hemostatic sponge with amben, hemostatic collagen sponge, etc.) are…

Read More Coagulants including blood clotting factors hemostatics

Fibrinolysis inhibitors inhibit fibrinolysis by competitive inhibition of the plasminogen-activating enzyme and inhibition of plasmin formation (aminocaproic acid, aminomethylbenzoic acid, etc.) or by complexing with plasmin (aprotinin). Regardless of the mechanism of inhibition of fibrinolysis, they have a specific hemostatic effect in various pathological conditions in which the fibrinolytic activity of blood and tissues is…

Read More Fibrinolysis inhibitors

Pharmacological group This pharmacological group includes such hematotropic agents as substitutes for plasma and other blood components in combinations. Below is a list of substitutes for plasma and other blood components in combinations: Potassium chloride + Calcium chloride + Magnesium chloride + Sodium bicarbonate + Sodium chloride + Povidone-8 thousand (Kalii chloridum + Calcii chloridum…

Read More Substitutes for plasma and other blood components in combinations

This pharmacological group includes such hematotropic agents as other hematotropic agents. Below is a list of other hematotropic agents: Ethyl {2- [2- (1-methylcarbamidamido) acetamido] acetate} (2E) -but-2-enedioate ()

Read More Other hematotropic

This pharmacological group includes such hematotropic agents as anticoagulants in combinations. Below is a list of anticoagulants in combinations: Escin + Essential Phospholipids + Sodium Heparin Heparin sodium + Dexpanthenol + Troxerutin Heparin sodium + [Allantoin + Dexpanthenol] Sodium Heparin + Benzocaine + Benzylnicotinate Heparin sodium + Prednisolone + Lauromacrogol 600 Heparin Sodium + Dexpanthenol…

Read More Anticoagulants in combinations